Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
- PMID: 34845317
- PMCID: PMC8727283
- DOI: 10.1038/s41375-021-01355-6
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
Erratum for
-
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.Leukemia. 2021 Jan;35(1):201-214. doi: 10.1038/s41375-020-0840-y. Epub 2020 Apr 29. Leukemia. 2021. PMID: 32350373 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
